Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;96:1031-1032
doi: 10.1161/01.RES.0000168921.55931.63
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Houser, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houser, S. R.
Related Collections
Right arrowRelated Article
(Circulation Research. 2005;96:1031.)
© 2005 American Heart Association, Inc.


Editorials

Can Novel Therapies for Arrhythmias Caused by Spontaneous Sarcoplasmic Reticulum Ca2+ Release be Developed Using Mouse Models?

Steven R. Houser

From the Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, Pa.

Correspondence to Steven R. Houser, Cardiovascular Research Center, Temple University School of Medicine, 3420 North Broad Street, Philadelphia, PA 19140, Email steven.houser@temple.edu



See related article, pages e77–e82


Key Words: cardiac arrhythmias • sarcoplasmic reticulum • ryanodine receptor • calcium regulation • heart failure


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Ventricular arrhythmias are a significant cause of premature death in Western society and occur both in the absence and presence of heart disease. For example, in heart failure close to 50% of patients die of lethal forms of ventricular arrhythmias. In spite of a large amount of basic and clinical investigations, current pharmacotherapy for ventricular arrhythmias is inadequate, demonstrating the need for novel therapeutic approaches.

Abnormal automaticity is responsible for induction and maintenance of different types of ventricular tachycardias. The form of abnormal automaticity that results from abnormal release of Ca2+ from a Ca2+ overloaded sarcoplasmic reticulum (SR), referred to as a "triggered arrhythmia", is the topic of this editorial. In vitro studies have shown that increasing the SR Ca2+ load beyond a critical level causes spontaneous opening of the SR Ca2+ release channel (ryanodine receptor; RYR) and results in spontaneous SR Ca2+ release.1 The subsequent increase in cytosolic [Ca] activates an inward current through the sarcolemmal Na+/ Ca2+ exchanger which causes membrane depolarization.1,2 Spontaneous SR Ca2+ release during the diastolic interval causes depolarization (delayed after depolarizations; DADs) which has been shown to result in action potentials in single cells and in the intact heart when the aberrant release is adequately synchronized within and among cardiac myocytes.3,4 Factors that lead to DADs include increased heart rate and catecholamine stress, which both induce triggered arrhythmias by increasing SR Ca2+ loading.3

Whereas many molecules are involved in SR Ca2+ overload (DAD) related arrhythmias, abnormal opening of the RYR is an essential . . . [Full Text of this Article]


Related Article:

Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor
Marina Cerrone, Barbara Colombi, Massimo Santoro, Marina Raffaele di Barletta, Mario Scelsi, Laura Villani, Carlo Napolitano, and Silvia G Priori
Circ. Res. 2005 96: e77-e82. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Eur J Heart FailHome page
D. von Lewinski, E. Bisping, A. Elgner, J. Kockskamper, and B. Pieske
Mechanistic insight into the functional and toxic effects of Strophanthidin in the failing human myocardium
Eur J Heart Fail, November 1, 2007; 9(11): 1086 - 1094.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Kockskamper and B. Pieske
Phosphorylation of the Cardiac Ryanodine Receptor by Ca2+/Calmodulin-Dependent Protein Kinase II: The Dominating Twin of Protein Kinase A?
Circ. Res., August 18, 2006; 99(4): 333 - 335.
[Full Text] [PDF]


Home page
HeartHome page
L Belardinelli, J C Shryock, and H Fraser
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine
Heart, July 1, 2006; 92(suppl_4): iv6 - iv14.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. H. George, H. Jundi, N. Walters, N. L. Thomas, R. R. West, and F. A. Lai
Arrhythmogenic Mutation-Linked Defects in Ryanodine Receptor Autoregulation Reveal a Novel Mechanism of Ca2+ Release Channel Dysfunction
Circ. Res., January 6, 2006; 98(1): 88 - 97.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. E. Anderson
The Fire From Within: The Biggest Ca2+ Channel Erupts and Dribbles
Circ. Res., December 9, 2005; 97(12): 1213 - 1215.
[Full Text] [PDF]